1st Quarter - Report
EXELIXIS INC. for EXELIXIS INC.
Firm
Client
Income
—
Expenses
$450,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Proposals related to drug pricing, including provisions of the Inflation Reduction Act. Administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES M. FENTON | — |
| ERIN HERMANCE | — |
| JARED DANIEL MICHAUD | — |
Taxation/Internal Revenue Code TAX
IRC Section 174 amortization of R&D expenditures
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES M. FENTON | — |
| ERIN HERMANCE | — |
| JARED DANIEL MICHAUD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.